Prospective Analysis of Arteriovenous Fistula Performance in the Context of Competing Risks

医学 背景(考古学) 动静脉瘘 血液透析 观察研究 前瞻性队列研究 外科 内科学 古生物学 生物
作者
Anukul Ghimire,Anita Lloyd,Susan K. Szigety,José Luis Merino,Karim Alibhai,Gerrit B. Winkelaar,Robert R. Quinn,Marcello Tonelli
出处
期刊:Kidney360 [American Society of Nephrology (ASN)]
标识
DOI:10.34067/kid.0000000650
摘要

Background: Many patients with newly created arteriovenous fistulas (AVF) may die before the AVF is needed for hemodialysis. However, formal competing risks frameworks are rarely used to report AVF patency, which may lead to biased estimates. We sought to identify the proportion of newly created AVF experiencing primary non-function and to describe long-term patency using a competing risk framework. Methods: We did a prospective observational study in 257 adults with newly created AVF in Alberta, Canada. The primary outcome was primary non-function. Secondary outcomes included loss of primary-patency, loss of assisted primary-patency, and loss of secondary functional-patency. Results were presented using icon-array plots to form the basis for future decision aids. Results: Participants were 63.0% male with mean age 62.3 years and median follow-up of 18.5 months (range 0.02-180 months). Of 257 participants, 50 could not be assessed for function or primary non-function, usually due to death. Of the remaining 207, 102 (49.3%) had primary non-function, and function was ultimately established for 142 (68.6%). Thus, only 142 of the 257 participants (55.3%) ultimately used the AVF for hemodialysis. High rates of competing risks led to biased results from Kaplan-Meier analyses of lost patency. When accounting for competing risks, loss of primary-patency among AVF with established function was 36.6%, 65.5% and 66.2%, at 1y, 3y and 5y respectively. Conclusions: Only 55% of fistulas were ultimately used for hemodialysis when accounting for competing risks and primary non-function. These results and the icon-array plots may inform discussions surrounding vascular access options for patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
咕咕发布了新的文献求助10
刚刚
着急的新瑶完成签到,获得积分10
2秒前
华仔应助佘子超采纳,获得10
4秒前
花开富贵完成签到,获得积分10
5秒前
5秒前
量子星尘发布了新的文献求助10
6秒前
usora完成签到,获得积分10
7秒前
8秒前
8秒前
高手如林完成签到,获得积分10
9秒前
康康完成签到 ,获得积分10
11秒前
wxy关闭了wxy文献求助
12秒前
12秒前
12秒前
13秒前
酷波er应助lucas采纳,获得10
13秒前
14秒前
饱满南松发布了新的文献求助10
14秒前
独特冰安发布了新的文献求助10
15秒前
罗里发布了新的文献求助10
16秒前
Yang发布了新的文献求助10
16秒前
Echo关注了科研通微信公众号
18秒前
18秒前
18秒前
19秒前
马里奥发布了新的文献求助10
19秒前
传奇3应助饱满南松采纳,获得10
20秒前
21秒前
今后应助李老头采纳,获得10
22秒前
包宇完成签到,获得积分20
23秒前
23秒前
23秒前
兜里全是糖完成签到,获得积分10
23秒前
姚大帅发布了新的文献求助10
24秒前
不懈奋进应助外向的安南采纳,获得30
25秒前
包宇发布了新的文献求助10
26秒前
马里奥完成签到,获得积分10
26秒前
lucas发布了新的文献求助10
27秒前
独特冰安发布了新的文献求助10
28秒前
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975426
求助须知:如何正确求助?哪些是违规求助? 3519848
关于积分的说明 11199831
捐赠科研通 3256122
什么是DOI,文献DOI怎么找? 1798124
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305